euda.com (EUDA): Forward Price-to-Revenue Multiple

EUDA Health (EUDA) - corporate logo

EUDA Health is a recognized leader in digital medicine in Asia, having earned patient trust through transparent pricing. The forward price-to-sales valuation trend illustrates market expectations, where 54.00 serves as the final level marker. Innovative software integrates insurance and telemedicine into a single application, creating a seamless environment. The active expansion of the health management ecosystem by 2026 confirms the high scaling potential of its services.

euda.com - EUDA Forward Price to Sales (period 04/28/2023 - 11/13/2026)

Metric breakdowns and analytics for euda.com (EUDA)

- current price and projected stock value:
Stock Price EUDA Health|EUDA - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Valuation EUDA|EUDA - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share EUDA Health|EUDA - Accounting Value of Company|Market Capitalization to Book Value Ratio euda.com|EUDA - Company Assets
- debt and solvency information:
Total Debt to Capital EUDA Health|EUDA - Long-Term Debt to Capital|Short-Term Debt to Equity EUDA Health Holdings Limited|EUDA - Company Debts|Debt to Book Value EUDA|EUDA - Amount of Long-Term Liabilities|Company Short-Term Debts EUDA Health|Quick Ratio euda.com
- financial results and valuation multiples details:
EUDA - Company Net Income|Future Profit EUDA Health|EUDA - P/E Multiple|Forward P/E Multiple EUDA Health|EUDA - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple EUDA|EUDA - Operating profit EBITDA|Net earnings per share for the last 12 months EUDA Health|EUDA - Earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months euda.com|EUDA - Earnings per share increase in current year|Earnings growth forecast for next year EUDA Health
- company sales and revenue statistics:
EUDA - Company Total Revenue|Projected Sales Volume EUDA Health Holdings Limited|EUDA - P/S Multiple|Forward Price-to-Revenue Multiple EUDA
Summary company analytics:EUDA Health (EUDA)
Product sample of EUDA Health Holdings Limited

EUDA Health is scaling its IT infrastructure for clinics through the automation of routine tasks, ensuring high operational efficiency with minimal staffing. By analyzing the forward P/S ratio, an investor can view the relationship between current market capitalization and expected revenue, which allows for tracking the dynamics of market expectations and determining the degree of asset overheating between quarterly reports, confirming the fundamental value of the scalable business model.

Competing companies

Forward P/S Multiple HCA (HCA Healthcare)|Forward P/S Multiple Tenet Healthcare Corp THC|FMS: Forward Price-to-Revenue Multiple|Forward Price to Sales SOLV (Solventum Health)|EHC: Forward P/S Multiple|Universal Health Services, Inc. - Forward Price to Sales|DVA (DaVita) - Forward P/S Multiple|Market Cap to Future Revenue Ratio RadNet Inc RDNT|Forward P/S Multiple OPCH|Forward P/S Multiple Surgery Partners Group (SGRY)|Price-to-Projected Revenue Ratio Premier, Inc. PINC|nationalvision.com - Price-to-Projected Revenue Ratio|PGNY: Forward Price-to-Revenue Multiple|Ardent Health - Price to Expected Revenue Ratio|SEM: Forward P/S Multiple|Astrana Corp - Forward Price to Sales|MD (Pediatrix Corp) - Forward P/S Multiple|Market Cap to Future Revenue Ratio US Physical Therapy Inc USPH|Forward Price-to-Revenue Multiple PNTG (The Pennant Group)|Forward P/S Multiple Organogenesis Holdings Inc. (ORGO)|Forward P/S Multiple NUTX (Nutex Health Corp)|AUNA: Market Cap to Projected Revenue|SBC Medical Corp - Forward P/S Multiple|EOLS - Forward P/S Multiple|CYH (Community Health Systems, Inc.) - Forward Price-to-Revenue Multiple|SKIN: Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio MediWound Ltd|BTMD: Forward Price to Sales|Forward P/S Multiple JYNT|DCGO - Market Cap to Future Revenue Ratio|Forward P/S Multiple PIII (P3 Health Partners)|Forward P/S Multiple Gain Therapeutics Inc. GANX|BMGL: Forward Price-to-Revenue Multiple|CollPlant Biotechnologies - Price to Expected Revenue Ratio|Cuprina Holdings (Cayman) Ltd (CUPR) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple concordmedical.com|AMS (American Shared Hospital Services) - Forward P/S Multiple|Market Cap to Future Revenue Ratio MEDIROM Healthcare Group Inc. MRM|Price-to-Projected Revenue Ratio Avalon GloboCare (ALBT)|DIH Group - Market Cap to Projected Revenue|Longevity Health Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio NIVF (newgenivf.com)|ATI Physical Therapy Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio CareMax Inc.|KDLY (Kindly MD Corp) - Forward Price-to-Revenue Multiple|ModivCare Corp (MODV) - Forward P/S Multiple|NVOS (Novo Integrated Sciences) - Forward P/S Multiple|Market Cap to Projected Revenue SSY (SunLink Health Systems, Inc)|Forward P/S Multiple BACK